Tulathromycin: An overview of a new triamilide antimicrobial for livestock respiratory disease

Veterinary Therapeutics

Volumn 6, Issue 2, 2005, Pages 83-95

  Evans, Nigel A ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DISACCHARIDE; HETEROCYCLIC COMPOUND; TULATHROMYCIN;

ANIMAL; ANIMAL DISEASE; AREA UNDER THE CURVE; CATTLE; CATTLE DISEASE; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; LUNG; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; REVIEW; SWINE;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CATTLE; DISACCHARIDES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HETEROCYCLIC COMPOUNDS; LUNG; MICROBIAL SENSITIVITY TESTS; PASTEURELLOSIS, PNEUMONIC; SWINE;

BOS TAURUS; BOVINAE; NEGIBACTERIA; SUS SCROFA;

EID: 24044526270     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Kamicker BJ, Mann DD, Hassfurther RC, et al: Therapeutic and metaphylactic activity of azalides and triamilides in the treatment of naturally occurring bovine respiratory disease [abstract D-26]. Proc 9th International Congress of the European Association for Veterinary Pharmacology and Therapeutics. J Vet Pharmacol Ther 26:233-234, 2003.
2. Kamicker BJ, Mann DD, Hassfurther RL, et al: Therapeutic and prophylactic activity of azalides and triamilides in the treatment of bovine respiratory disease [abstract D-27]. Proc 9th International Congress of the European Association for Veterinary Pharmacology and Therapeutics. J Vet Pharmacol Ther 26:234, 2003.
3. Letavic MA, Bronk BS, Bertsche CD, et al: Synthesis and activity of a novel class of tribasic macrocyclic antibiotics: The triamilides. Bioorg Med Cbem Lett 12:2771-2774, 2002.
4. Norcia LJ, Silvia AM, Santoro SL, et al: In vitro microbiological characterization of a novel azalide, two triamilides and an azalide ketal against bovine and porcine respiratory pathogens. J Antibiot (Tokyo) 57:280-288, 2004.
5. Godinho KS, Keane SG, Nanjiani IA, et al: Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology. Vet Ther 6(2):113-121, 2005.
6. National Committee for Clinical Laboratory Standards (NCCLS; now Clinical and Laboratory Standards Institute [CLSI]): Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals (approved standard]. Doc. No. M31-A2, ed 2, 2002.
7. National Committee for Clinical Laboratory Standards (NCCLS; now Clinical and Laboratory Standards Institute [CLSI]): Methods for Determining Bactericidal Activity of Antimicrobial Agents [approved guideline]. Doc. No. M26 - A, 1999.
8. 2, and serum) on MIC values of tulathromycin against Haemophilus somnus [abstract 532]. Proc 23rd World Buiatrics Congr:70-71, 2004.
9. Pruul H, McDonald PJ: Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum. Antimicrob Agents Chemother 36:10-16, 1992.
10. Nowakowski MA, Inskeep P, Risk J, et al: Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic, in cattle. Vet Ther 5:60-74, 2004.
11. Benchaoui RA, Nowakowski MA, Sherington J, et al: Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. J Vet Pharmacol Ther 27:203-210, 2004.
12. Evans NA, Skogerboe TL, Mann DD, et al: Therapeutic efficacy of tulathromycin against naturally occurring bovine respiratory disease [poster abstract 511]. Poster Abstracts Proc 23rd World Buiatrics Congr:66-67, 2004.
13. Nutsch RG, Skogerboe TL, Rooney KA, et al: Comparative efficacy of tulathromycin, tilmicosin, and florfenicol in the treatment of bovine respiratory disease in stocker cattle. Vet Ther 6(2):167-179, 2005.
14. Nanjiani IA, McKelvie J, Benchaoui HA, et al: Evaluation of the therapeutic activity of tulathromycin against swine respiratory disease on farms in Europe. Vet Ther 6(2):203-213, 2005.
15. McKellar QA, Sanchez Bruni SF, Jones DG: Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. J Vet Pharmacol Ther 27:503-514, 2004.
16. Gladue RP, Bright GM, Isaacson RE, Newborg MF: In vitro and in vivo uptake of azithromycin (CP-62, 995) by phagocytic cells: Possible mechanisms of delivery and release at sites of infection. Antimicrob Agents Chemother 33:277-282, 1989.
17. Siegel TW, Earley DL, Smothers CD, et al: Cellular uptake of the triamilide tulathromycin by bovine and porcine phagocytic cells in vitro. J Anim Sci 82(suppl 1):186, 2004.
18. Rooney KA, Nutsch RG, Skogerboe TL, et al: Efficacy of tulathromycin compared with tilmicosin and florfenicol for the control of respiratory disease in cattle at high risk of developing bovine respiratory disease. Vet Ther 6(2):154-166, 2005.
19. Skogerboe TL, Rooney KA, Nutsch RG, et al: Comparative efficacy of tulathromycin versus florfenicol and tilmicosin against undifferentiated bovine respiratory disease in feedlot cattle. Vet Ther 6(2):180-196, 2005.
20. Nutsch RG, Hart FJ, Rooney KA, et al: Efficacy of tulathromycin injectable solution for the treatment of naturally occurring swine respiratory disease. Vet Ther 6(2):214-224, 2005.